Nystatin Bulk Powder Recalled Due to Incorrect Label Strength
Fagron Inc. is recalling 9 containers of Nystatin 2 BU bulk powder because the assay value on the label is incorrect, which could affect dosing accuracy in pharmacy compounding.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a pharmaceutical used in prescription compounding where incorrect declared strength could lead to dosing errors. FDA Class II classification indicates the agency considers this significant. Although no illnesses have been reported, the potential for harm from incorrect dosing information justifies this rating.
Plain-English summary
Fagron Inc. is recalling Nystatin 2 BU bulk powder intended for prescription compounding. Nine containers with NDC 51552-0041-4 are affected, specifically lot numbers 230308-U46224 and 221031-U42105, both expiring April 30, 2025.
The recall was initiated due to a label error: the assay value on the label is incorrect. This affects the declared strength of the nystatin in the bulk powder.
The product was distributed to one distributor, which may have further distributed it to repacker/relabelers and pharmacies in the United States and Canada for prescription compounding purposes.
The recalled product
- Product
- NYSTATIN 2 BU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding, Fagron, Inc. - 2400 Pilot Knob Rd. St Paul, MN 55120. NDC 51552-0041-4, Bar code 3 51552 00414 6
- Manufacturer
- Fagron, Inc
- Category
- Drug
- Affected units
- 9
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: 230308-U46224
- Exp. date 04/30/2025
- 221031-U42105
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 4 recalled by Fagron, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Fagron, Inc
See all →- HighNystatin Bulk Powder Recall for Incorrect Label Assay Value
FDA (Drugs) · 2023-12-27
- HighNystatin bulk powder recall due to incorrect assay strength label
FDA (Drugs) · 2023-12-27
- HighNystatin Powder Recall Due to Incorrect Assay Strength on Label
FDA (Drugs) · 2023-12-27
- ModeratePrescription Compounding Drug Nandrolone Decanoate Recalled for Subpotency
FDA (Drugs) · 2022-05-18
- ModerateFDA Recalls Subpotent Nandrolone Decanoate Compounding Ingredient
FDA (Drugs) · 2022-05-18
Same hazard · labeling error
See all →- ModerateLiquid Hope Organic Meal Replacement Formula Subpotent Vitamin A Recall
FDA (Food) · 2026-07-22
- ModerateOrthofix MINIRAIL external fixation devices recalled for incorrect model labeling
FDA (Devices) · 2026-07-22
- Moderate
- HighPerampanel Prescription Tablets Recalled for Labeling Mix-up
FDA (Drugs) · 2026-07-01
- SevereAzuma Foods Tako Wasabi seasoned octopus contains undeclared fish
FDA (Food) · 2026-06-24